The independent source for health policy research, polling, and news.
381-400 of 835 results
The promising antiviral drugs to treat covid can halt hospitalizations and deaths, but only if they’re given to patients within three to five days of their first symptoms, a narrow window many people won’t meet. Here’s why.
Some business owners, wondering whether it’s too soon to ease the requirement, long for more guidance and support from the mayor.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
But state and local officials embrace the requirement because it creates a safer workplace while allowing employees to continue working.
Federal health officials appear poised to extend a recommendation for covid boosters to all adults, following moves by some governors and mayors to broaden the eligible booster pool as caseloads rise. Meanwhile, the Food and Drug Administration finally has a nominee to head the agency: former FDA chief Robert Califf. And Medicare premiums for consumers will likely rise substantially in 2022, partly due to the approval of a controversial drug to treat Alzheimer’s disease. Tami Luhby of CNN, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dan Weissmann, host of the “An Arm and a Leg” podcast.
Health officials hope the rollout of covid shots for young children and other initiatives will boost routine vaccine rates that dropped during the pandemic and narrow socioeconomic disparities.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
KHN gives readers a chance to comment on a recent batch of stories.
Congress is making slow progress toward completing its ambitious social spending bill, although its Thanksgiving deadline looks optimistic. Meanwhile, a new survey finds the average cost of an employer-provided family plan has risen to more than $22,000. That’s about the cost of a new Toyota Corolla. Alice Miranda Ollstein of Politico, Anna Edney of Bloomberg News and Rebecca Adams of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Rebecca Love, a nurse academic and entrepreneur, about the impending crisis in nursing.
A health center with clinics on Chicago’s southwest side that serves mostly Hispanic patients has provided the most covid shots to kids in the city by being accessible, (literally) speaking the language of the community and setting up pop-up clinics at schools and parks. It provides a few lessons as the nation gears up to vaccinate 5- to 11-year-olds.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
A former Montana health department leader said Republican Gov. Greg Gianforte’s administration killed a public service campaign planned for last summer that promoted covid vaccines for teens. Health organizations want to fill the void with information on vaccines for children 5 and up.
Some front-line workers who die of covid-19 have been considered eligible for accidental death benefits because it is presumed their infection was contracted on the job. But some employers now suggest that if the workers didn’t follow established safety protocols, such as getting vaccinated, those benefits may be denied.
Reports of waning effectiveness and mixed messages about booster shots fuel the politicization of vaccination.
California offers a lens on the challenges officials face in persuading parents to embrace covid shots for young children. While the state has a strong showing in overall vaccination rates, just 59% of kids 12 to 17 — eligible for a shot since May — are fully vaccinated.
A federal allocation plan meant to ensure equitable distribution of powerful monoclonal antibody treatments for high-risk patients fails to prioritize nursing home residents, a population that remains particularly vulnerable even after vaccination.
President Joe Biden unveiled a compromise “Build Back Better” framework shortly before taking off for key meetings in Europe, but it’s unclear whether the framework can win the votes of all Democrats in the House and Senate, and it leaves out some of the party’s health priorities, notably significant provisions to lower prescription drug prices. Meanwhile, younger children may soon be eligible for covid vaccines. Joanne Kenen of Politico and Johns Hopkins, Sarah Karlin-Smith of the Pink Sheet and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more.
The covid vaccination rate for first responders in the state is more than 95%. But it's lower in more rural areas, where ambulance crews can't function if even just a few people quit.
Negotiations on the health parts of President Joe Biden’s domestic agenda are getting serious but have yet to produce a deal every Democrat can support. Meanwhile, the Food and Drug Administration remains without a nominated leader but manages to take the first steps toward approving over-the-counter hearing aids. Joanne Kenen of Politico and Johns Hopkins, Tami Luhby of CNN and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read too.
With Kentucky in the grip of a covid surge, public health workers are taking their vaccination campaign house to house and church to church, trying to outmaneuver the fantastical tales spread on social media and everyday hurdles of hardship and isolation.
© 2026 KFF